Sinovent Stock

Sinovent is engaged in the technical development, consulting, and services of biological medicines.

Sign up today and learn more about Sinovent Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Sinovent Stock

Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.

Funding History

August 2020$1.0B
February 2024$700M

Management

Chairman & Founder

Jing Qiang

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo